MCADD

(redirected from Medium chain acyl-CoA dehydrogenase deficiency)
AcronymDefinition
MCADDMedium Chain Acyl-Coa Dehydrogenase Deficiency (an inherited error of fatty acid metabolism)
MCADDMaryland Center for Attention and Developmental Disorders (University of Maryland Medical System; Baltimore, MD)
References in periodicals archive ?
Maier et al., "Reduced incidence of severe metabolic crisis or death in children with medium chain acyl-CoA dehydrogenase deficiency homozygous for c.985A>G identified by neonatal screening," Molecular Genetics and Metabolism, vol.
Those babies who have their newborn bloodspot sample from this month will be offered screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD).
Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.
Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies.
Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies.
MCADD (medium chain acyl-coa dehydrogenase deficiency) (1 in 10,000 risk) where the baby cannot break down fats to make energy for the body.
Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK.
Medium chain acyl-CoA dehydrogenase deficiency human genome epidemiology review.
Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)--MCAD is characterized by recurrent episodes of metabolic acidosis, and by hypoglycemia, lethargy, and coma.
Morbidity and mortality in medium chain acyl-CoA dehydrogenase deficiency. Arch Dis Child 1994;70:410-12.
Full browser ?